Humans on Demand with Dr. Drew Taylor | Sense Making Conversations
This conversation was recorded live. In this Sense Making Conversation, our host, Andrea Sampson, CEO of Talk Boutique, converses with Dr. Drew Taylor.
When the movie “Gattaca” premiered in 1997, promoters took out ads in local newspapers advertising genetically engineered babies. It created quite a stir… however it was just a publicity stunt… genetic engineering was still seen to be in the far future for humans.
Well, that future has arrived, with breakthroughs in science and the advent of regenerative medicine, genetic engineering is becoming a mainstream conversation.
Join Andrea as she speaks with Dr. Drew Taylor, about some of the latest advances in science, genetic engineering and why you might want to be banking your stem cells now!
—-
About Dr. Drew Taylor, PhD, Co-Founder and CEO of Acorn Biolabs
Dr. Drew Taylor is Co-Founder and Chief Executive Officer at Acorn Biolabs. Biologist and former professional athlete, Drew has charted his path across molecular cell biology, science and baseball with steadfast passion over his career. He completed an undergraduate degree in Biology at the University of Michigan and a Masters from the same school in Molecular, Cellular, Developmental Biology. He also completed his Ph.D. with the University of Toronto in Biomedical Engineering.
Drew has enjoyed a successful career in professional minor league baseball as a pitcher for both the Toronto Blue Jays and the Philadelphia Phillies, charting parallel paths across both professional sports and science. Prior to joining Acorn, Drew spent several years as Chief Science Officer at Epic Capital Management working across the flourishing biotech start-up community, and prior to that, he was part of the Mount Sinai Hospital Bioengineering of Skeletal Tissues Team.
He has been widely published across international medical journals with a specific focus on tissue engineering and sports medicine. Drew’s current mandate is to lead Acorn Biolabs to bring accessible, non-invasive and affordable live cell collection and preservation to consumers everywhere.